When complex financial problems arise, Gleason Experts helps clients minimize risk exposure, consider alternative scenarios, project results and take advantage of strategic opportunities.
Gleason IP takes a client-focused, cost-effective approach to IP issues, delivering insightful economic and financial analyses across a range of industries, with particular knowledge/expertise in Pharma/Life Sciences.
Gleason Trust has decades of experience in trust accounting, trust management and administration, and providing high-quality service to meet the fiduciary needs of a variety of trusts.
Gleason Advisors provides valuable financial and strategic advice to closely held, private companies throughout the business life cycle. Our experience spans multiple industries and challenges.
Delaware Chief Judge Connolly Credits Ivan Hofmann’s Commercial Success Testimony in a Pharmaceutical Patent Case Gleason IP was retained by multiple defendants in a patent infringement matter related to Taiho Pharmaceutical Co., Ltd. and Taiho Oncology, Inc.’s Lonsurf® (trifluridine and tipiracil) tablets. Lonsurf® tablets are a prescription medicine for stomach cancer (sometimes referred to... Read More
Federal Circuit Affirms the Use of Blocking Patents in a Commercial Success Inquiry In the patent litigation between UCB and Actavis related to the reformulated Neupro® patch, the Federal Circuit affirmed the District Court’s decision regarding Ivan Hofmann’s testimony related to blocking patents that dissuaded competitors from developing a rotigotine patch that practiced the claimed... Read More